SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹74,248 Cr | ₹67,191 Cr | ₹61,462 Cr | ₹59,424 Cr | ₹56,337 Cr |
Sales | ₹73,641 Cr | ₹66,963 Cr | ₹61,197 Cr | ₹58,912 Cr | ₹55,958 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹607 Cr | ₹228 Cr | ₹265 Cr | ₹512 Cr | ₹380 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹43,886 Cr | ₹38,654 Cr | ₹33,498 Cr | ₹32,838 Cr | ₹29,066 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-687 Cr | ₹-108 Cr | ₹-638 Cr | ₹301 Cr | ₹-433 Cr |
Raw Material Consumed | ₹11,349 Cr | ₹10,459 Cr | ₹9,328 Cr | ₹8,930 Cr | ₹8,302 Cr |
Opening Raw Materials | ₹2,914 Cr | ₹3,344 Cr | ₹2,894 Cr | ₹2,784 Cr | ₹2,462 Cr |
Purchases Raw Materials | ₹8,342 Cr | ₹6,618 Cr | ₹6,604 Cr | ₹5,625 Cr | ₹6,104 Cr |
Closing Raw Materials | ₹3,478 Cr | ₹2,914 Cr | ₹3,344 Cr | ₹2,894 Cr | ₹2,784 Cr |
Other Direct Purchases / Brought in cost | ₹3,572 Cr | ₹3,410 Cr | ₹3,175 Cr | ₹3,414 Cr | ₹2,519 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹830 Cr | ₹703 Cr | ₹596 Cr | ₹586 Cr | ₹580 Cr |
Electricity & Power | ₹830 Cr | ₹703 Cr | ₹596 Cr | ₹586 Cr | ₹580 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹8,296 Cr | ₹7,301 Cr | ₹6,126 Cr | ₹5,704 Cr | ₹5,298 Cr |
Salaries, Wages & Bonus | ₹7,340 Cr | ₹6,444 Cr | ₹5,399 Cr | ₹5,045 Cr | ₹4,664 Cr |
Contributions to EPF & Pension Funds | ₹514 Cr | ₹469 Cr | ₹374 Cr | ₹361 Cr | ₹320 Cr |
Workmen and Staff Welfare Expenses | ₹378 Cr | ₹336 Cr | ₹304 Cr | ₹261 Cr | ₹276 Cr |
Other Employees Cost | ₹63 Cr | ₹52 Cr | ₹48 Cr | ₹37 Cr | ₹37 Cr |
Other Manufacturing Expenses | ₹1,937 Cr | ₹1,881 Cr | ₹3,487 Cr | ₹3,342 Cr | ₹3,399 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹561 Cr | ₹558 Cr | ₹542 Cr | ₹618 Cr | ₹667 Cr |
Repairs and Maintenance | ₹657 Cr | ₹525 Cr | ₹473 Cr | ₹403 Cr | ₹464 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹719 Cr | ₹798 Cr | ₹2,472 Cr | ₹2,321 Cr | ₹2,268 Cr |
General and Administration Expenses | ₹4,256 Cr | ₹3,271 Cr | ₹2,225 Cr | ₹2,431 Cr | ₹2,033 Cr |
Rent , Rates & Taxes | ₹729 Cr | ₹649 Cr | ₹417 Cr | ₹385 Cr | ₹336 Cr |
Insurance | ₹299 Cr | ₹262 Cr | ₹230 Cr | ₹192 Cr | ₹144 Cr |
Printing and stationery | ₹67 Cr | ₹61 Cr | ₹51 Cr | ₹46 Cr | ₹44 Cr |
Professional and legal fees | ₹2,312 Cr | ₹1,803 Cr | ₹1,168 Cr | ₹1,147 Cr | ₹879 Cr |
Traveling and conveyance | ₹642 Cr | ₹374 Cr | ₹237 Cr | ₹543 Cr | ₹527 Cr |
Other Administration | ₹849 Cr | ₹496 Cr | ₹359 Cr | ₹661 Cr | ₹631 Cr |
Selling and Distribution Expenses | ₹5,226 Cr | ₹4,096 Cr | ₹3,104 Cr | ₹3,654 Cr | ₹2,621 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | ₹207 Cr | ₹195 Cr | ₹203 Cr | ₹213 Cr | ₹112 Cr |
Freight and Forwarding | ₹934 Cr | ₹793 Cr | ₹622 Cr | ₹572 Cr | ₹515 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹4,085 Cr | ₹3,108 Cr | ₹2,278 Cr | ₹2,870 Cr | ₹1,994 Cr |
Miscellaneous Expenses | ₹1,217 Cr | ₹1,170 Cr | ₹803 Cr | ₹916 Cr | ₹992 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | ₹43 Cr | ₹18 Cr | ₹4.31 Cr | ₹107 Cr | - |
Losson disposal of fixed assets(net) | ₹3.65 Cr | ₹14 Cr | ₹2.24 Cr | ₹8.69 Cr | ₹69 Cr |
Losson foreign exchange fluctuations | ₹126 Cr | - | - | - | ₹93 Cr |
Losson sale of non-trade current investments | - | - | - | - | ₹0.01 Cr |
Other Miscellaneous Expenses | ₹1,044 Cr | ₹1,139 Cr | ₹797 Cr | ₹800 Cr | ₹830 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹32,424 Cr | ₹28,773 Cr | ₹25,030 Cr | ₹25,863 Cr | ₹22,792 Cr |
Operating Profit (Excl OI) | ₹11,461 Cr | ₹9,882 Cr | ₹8,468 Cr | ₹6,974 Cr | ₹6,274 Cr |
Other Income | ₹820 Cr | ₹1,437 Cr | ₹859 Cr | ₹652 Cr | ₹1,059 Cr |
Interest Received | ₹385 Cr | ₹553 Cr | ₹211 Cr | ₹355 Cr | ₹669 Cr |
Dividend Received | ₹146 Cr | ₹215 Cr | ₹256 Cr | ₹56 Cr | ₹22 Cr |
Profit on sale of Fixed Assets | ₹11 Cr | ₹49 Cr | ₹16 Cr | ₹3.47 Cr | ₹2.83 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹15 Cr | ₹5.98 Cr | ₹12 Cr | ₹5.22 Cr | ₹40 Cr |
Foreign Exchange Gains | - | ₹154 Cr | ₹24 Cr | ₹16 Cr | - |
Others | ₹263 Cr | ₹460 Cr | ₹340 Cr | ₹216 Cr | ₹325 Cr |
Operating Profit | ₹12,281 Cr | ₹11,319 Cr | ₹9,327 Cr | ₹7,626 Cr | ₹7,333 Cr |
Interest | ₹172 Cr | ₹127 Cr | ₹141 Cr | ₹303 Cr | ₹555 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹172 Cr | ₹127 Cr | ₹141 Cr | ₹303 Cr | ₹555 Cr |
PBDT | ₹12,109 Cr | ₹11,192 Cr | ₹9,185 Cr | ₹7,323 Cr | ₹6,778 Cr |
Depreciation | ₹2,529 Cr | ₹2,144 Cr | ₹2,080 Cr | ₹2,053 Cr | ₹1,753 Cr |
Profit Before Taxation & Exceptional Items | ₹9,580 Cr | ₹9,048 Cr | ₹7,106 Cr | ₹5,270 Cr | ₹5,025 Cr |
Exceptional Income / Expenses | ₹-171 Cr | ₹-4,567 Cr | ₹-4,306 Cr | ₹-261 Cr | ₹-1,214 Cr |
Profit Before Tax | ₹9,408 Cr | ₹4,481 Cr | ₹2,799 Cr | ₹5,010 Cr | ₹3,810 Cr |
Provision for Tax | ₹848 Cr | ₹1,076 Cr | ₹515 Cr | ₹823 Cr | ₹601 Cr |
Current Income Tax | ₹1,869 Cr | ₹354 Cr | ₹957 Cr | ₹1,320 Cr | ₹804 Cr |
Deferred Tax | ₹-1,022 Cr | ₹721 Cr | ₹-443 Cr | ₹-497 Cr | ₹-203 Cr |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹8,561 Cr | ₹3,406 Cr | ₹2,285 Cr | ₹4,187 Cr | ₹3,209 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-39 Cr | ₹-117 Cr | ₹631 Cr | ₹-407 Cr | ₹-542 Cr |
Share of Associate | ₹-48 Cr | ₹-17 Cr | ₹-12 Cr | ₹-15 Cr | ₹-1.46 Cr |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹8,474 Cr | ₹3,273 Cr | ₹2,904 Cr | ₹3,765 Cr | ₹2,665 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹37,646 Cr | ₹36,598 Cr | ₹35,320 Cr | ₹33,330 Cr | ₹31,978 Cr |
Appropriations | ₹46,119 Cr | ₹39,871 Cr | ₹38,224 Cr | ₹37,095 Cr | ₹34,643 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | ₹57 Cr | - |
Other Appropriation | ₹710 Cr | ₹546 Cr | ₹307 Cr | ₹998 Cr | ₹1,313 Cr |
Equity Dividend % | ₹1,150.00 | ₹1,000.00 | ₹750.00 | ₹400.00 | ₹275.00 |
Earnings Per Share | ₹35.32 | ₹13.64 | ₹12.10 | ₹15.69 | ₹11.11 |
Adjusted EPS | ₹35.32 | ₹13.64 | ₹12.10 | ₹15.69 | ₹11.11 |
Compare Income Statement of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹367,284.8 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics | |
MANKIND PHARMA | ₹84,596.1 Cr | -6.1% | -11.9% | 54.1% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.9% |
0.9% |
62.6% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses